Amlodipine 5mg
Sponsors
AstraZeneca, Boehringer Ingelheim, HK inno.N Corporation, Chong Kun Dang Pharmaceutical, Shin Poong Pharmaceutical Co. Ltd.
Conditions
Adverse EventAortic RegurgitationAortic StenosisBlood PressureCardiovascular Risk FactorDiabetes MellitusDiabetes Mellitus, Type 2Essential Hypertension
Phase 1
Phase 2
A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
NCT02059616
Start: 2014-02-28End: 2015-12-31Target: 384Updated: 2014-04-30
A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
NCT02206165
Start: 2014-03-31End: 2015-06-30Target: 456Updated: 2015-03-30
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
CompletedNCT02944734
Start: 2014-09-30End: 2015-12-31Updated: 2016-11-22
Treatment of Early Hypertension Among Persons Living With HIV in Haiti
CompletedNCT04692467
Start: 2021-02-26End: 2023-12-30Updated: 2024-04-09
Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index
WithdrawnNCT04954196
Start: 2021-10-08End: 2024-09-08Updated: 2023-03-13
Phase 3
An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
CompletedNCT01103960
Start: 2010-07-31Updated: 2014-06-27
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
CompletedNCT02368665
Start: 2014-12-31End: 2016-11-30Updated: 2023-05-06
CKD-330 Phase 3 Trial in Amlodipine Non-responder
CompletedNCT02586311
Start: 2016-01-31End: 2016-09-30Updated: 2016-10-06
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
CompletedNCT02651870
Start: 2015-04-22End: 2016-02-29Updated: 2020-08-25
Phase 4
A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
CompletedNCT00819104
Start: 2008-11-30End: 2009-08-31Updated: 2009-09-09
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
RecruitingNCT03264352
Start: 2018-02-01End: 2025-09-30Target: 11414Updated: 2025-03-12
Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
CompletedNCT03666351
Start: 2018-10-18End: 2022-07-25Updated: 2022-09-15
Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes
WithdrawnNCT03978884
Start: 2019-06-01End: 2020-12-31Updated: 2020-09-03
Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension
NCT04474899
Start: 2015-06-24End: 2024-06-24Target: 120Updated: 2022-09-29
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
NCT05165251
Start: 2022-01-04End: 2025-06-01Target: 480Updated: 2023-02-15
Unknown Phase
Gut Microbiomes in Patients With Metabolic Syndrome
NCT03489317
Start: 2017-11-27End: 2021-12-31Target: 1000Updated: 2018-07-23
Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension
NCT04554303
Start: 2020-10-28End: 2022-05-23Target: 80Updated: 2020-11-12